Monthly Archives: October 2017
CAR T-Cell Therapy HCP Guide – Updates from the FDA
CAR T-Cell FDA Approval: Status Update
In addition to the approval of Kymriah, Yescarta (axicabtagene ciloleucel or Axi-Cel) was approved on October 18,...
VIDEO: CAR T-cell Therapy for Pediatric Leukemia: Sam’s Story
Published September 18, 2017
CAR T-cell therapy is a revolutionary immunotherapy treatment that supercharges a patient's own blood cells to seek out and destroy...
Immune Status Tied to Outcomes in Third-Gen CAR T-Cell Therapy
September 6, 2017 (HealthDay News)
In leukemia/lymphoma, after treatment CD19-targeting chimeric antigen receptor T-cell therapy
Outcomes of treatment with third-generation CAR T-cell therapy in CD19-positive...
